Oxford Biomedica Solutions
Tyler Peters is a manager in Drug Product MS&T at Sarepta Therapeutics since September 2023. Previously, Tyler served as CMC Program Lead and Senior Research Associate II at Oxford Biomedica Solutions from March 2022 to September 2023, and held multiple roles in drug product development, including Senior Research Associate II and Research Associate at Homology Medicines, Inc. from December 2019 to March 2022. Earlier experience includes positions as Research and Development Scientist I and Research and Development Intern at Ocular Therapeutix, Inc. from June 2015 to December 2019. Tyler Peters earned a Bachelor's degree in Biology/Biological Sciences from the University of Massachusetts Lowell in 2018.
This person is not in the org chart
This person is not in any teams
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.